PPT-Does my patient on chronic opioids have pain, opioid use disorder,

or both Joshua Blum MD February 17 2021 Objectives Understand the overlapping prevalence and features of chronic pain and addiction Describe the continuum from chronic pain to opioid use disorder and recognize where individual patients are positioned on this continuum. Outpatient Opioid Therapy: Mitigating Risks. Perry G. Fine, MD . Professor . of Anesthesiology. Department . of . Anesthesiology . School . of Medicine. University of Utah. O. bjectives. Be informed of content, intent and limitation of current Clinical Guidelines. . Melissa B. Weimer, DO, MCR. Disclosures. Dr. Weimer is a consultant for . INFORMed. , IMPACT education, and the American Association of Addiction Psychiatry.. Dr. Weimer is the medical director of CODA, Inc. . Rebecca . King MSN, . MEd, RN. a. nd. Paula Fields MSN, RN. Coordinators. WVDE-Office of Special Programs. Objectives. Participants will be able to:. Understand . the epidemiology of chronic pain and misuse of opioids;. Annie Ottney, . PharmD. , BCPS. Learning Objective. Identify non-opioid medications that can be used in the management of chronic pain. Opioid Epidemic . Concurrent use of opioids and benzodiazepines across United States is HIGH. PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine. Assessing Opioid Use Disorder, part . 2. Objectives. Identify key features of opioid use disorder.. Understand . the evaluation of opioid use disorder in the setting of chronic pain.. MPhA. MTM Fall Symposium. Kathryn Perrotta, . PharmD. , MBA, BCPS. November 16, 2012. Disclosure Statement. Define the health economic impact of the use of . opioid. analgesics in the treatment of pain . Appropriate Opioid Medication Use as Part of a Comprehensive Pain Management Approach MPhA MTM Fall Symposium Kathryn Perrotta, PharmD , MBA, BCPS November 16, 2012 Disclosure Statement Define the health economic impact of the use of Dean Drosnes, MD, FASAM. Associate Medical Director. Director, Chronic Pain Treatment Program. Caron Treatment Centers. Disclosures. Name. Commercial Interests. Relevant Financial Relationships: What Was Received. Immersion Training in Addiction Medicine Programs 2021. May 2021. Daniel P. Alford, MD, MPH. Professor of Medicine. Associate Dean, Continuing Medical Education. Director, Clinical Addiction Research and Education (CARE) Unit. This presentation is based on . the September 2014. AHRQ . WebM&M. Spotlight Case. See the full article at . http://webmm.ahrq.gov. . CME credit is available. Commentary by: . Shoshana J. Herzig, MD, MPH. Feedback from the Oxford Advanced Pain and Symptom Management Course –July 18. Anne Hounsell, Speciality Doctor, The Rowans Hospice. 6/12/18. Objectives. The use of opioids in CNCP-risks and benefits.. A Responsibility to Protect. C. Scott Anthony, D.O.. Pain Management of Tulsa. Disclosure. I . have no relevant financial relationships or affiliations with commercial interests to disclose.. Recent Actions. with . Traumatic Brain Injury . Shashank J. Davé, DO, FAAPMR. Clinical Associate Professor. Department of Physical Medicine & Rehabilitation. Department of Neurology. Indiana University School of Medicine. Rachael . Rzasa. Lynn, MD. Shared Learning Call. 22 – 9 – 22. Colorado DORA Guidelines. (3/2019). Prior to prescribing opioids: . ✅ Develop and Maintain Competence. ✅ Diagnose and Evaluate Patient.